Jing Zheng Selected Research

12S ribosomal RNA

1/2018	Contribution of the tRNAIle 4317A→G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A→G mutation.
11/2015	Mitochondrial haplogroup B increases the risk for hearing loss among the Eastern Asian pedigrees carrying 12S rRNA 1555A>G mutation.
4/2015	[Mitochondrial tRNA(Thr)T15943C mutation may be a new position that affects the phenotypic expression of deafness associated 12s rRNA A1555G mutation].
11/2014	[Function study of non-syndromic deafness associated mitochondrial 12S rRNA A839G mutation].
6/2013	[Mitochondrial tRNAIle A4317G mutation may influence the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation].
1/2013	[Mitochondrial 12S rRNA A1555G mutation associated with nonsyndromic hearing loss in twenty-five Han Chinese pedigrees].
12/2012	[Mitochondrial 12S rRNA variants studies in 456 subjects with hearing loss in seven schools for deaf and mutes in Zhejiang province].
8/2012	[Characterization of two Chinese families with aminoglycoside-induced and nonsyndromic hearing loss both carrying a mitochondrial 12S rRNA 1494C>T mutation].
6/2012	[Spectrum and frequency of mitochondrial 12S rRNA variants in the Chinese subjects with nonsynrdomic hearing loss in Zhejiang Province].
6/2012	The 12S rRNA A1555G mutation in the mitochondrial haplogroup D5a is responsible for maternally inherited hypertension and hearing loss in two Chinese pedigrees.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing Zheng Research Topics

Disease

71	Neoplasms (Cancer) 12/2022 - 07/2009
23	Deafness (Deaf Mutism) 01/2021 - 03/2009
23	Hearing Loss (Hearing Impairment) 12/2020 - 05/2003
22	Hypoxia (Hypoxemia) 01/2022 - 12/2013
15	Infections 01/2022 - 12/2007
13	Inflammation (Inflammations) 11/2021 - 06/2012
12	Neoplasm Metastasis (Metastasis) 02/2022 - 07/2009
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2014
11	Nonsyndromic Deafness 01/2017 - 01/2010
8	Body Weight (Weight, Body) 01/2018 - 10/2012
7	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2015
7	Hypertension (High Blood Pressure) 01/2022 - 06/2012
7	Adenocarcinoma of Lung 10/2020 - 01/2012
6	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 10/2013
6	Chronic Renal Insufficiency 01/2022 - 01/2011
6	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 05/2012
6	Human Influenza (Influenza) 01/2020 - 08/2013
6	Ototoxicity 01/2020 - 06/2010
6	Pre-Eclampsia (Preeclampsia) 01/2019 - 04/2010
5	Lung Neoplasms (Lung Cancer) 11/2021 - 02/2014
5	Obesity 08/2021 - 07/2014
5	Leukemia 08/2021 - 10/2005
5	Glioma (Gliomas) 01/2018 - 03/2013
5	Thymoma (Thymic Carcinoma) 01/2018 - 01/2008
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2016
4	Non-alcoholic Fatty Liver Disease 08/2021 - 07/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 12/2012
4	Multiple Myeloma 01/2021 - 01/2017
4	Allergic Rhinitis 02/2020 - 01/2012
4	Asthma (Bronchial Asthma) 05/2019 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2013
4	Myeloid Leukemia (Leukemia, Myelocytic) 01/2012 - 10/2005
3	Hemorrhage 07/2022 - 01/2019
3	Nasopharyngeal Carcinoma 05/2022 - 01/2019
3	Nasal Polyps (Nasal Polyp) 03/2022 - 06/2012
3	Brain Injuries (Brain Injury) 02/2022 - 03/2014
3	COVID-19 01/2022 - 12/2020
3	Carcinogenesis 01/2022 - 12/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 11/2014
3	Hypotension (Low Blood Pressure) 01/2021 - 09/2019
3	Lymphatic Metastasis 10/2020 - 07/2009

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2003
18	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2010
15	Pharmaceutical PreparationsIBA 01/2021 - 02/2006
14	12S ribosomal RNAIBA 01/2018 - 01/2010
14	AminoglycosidesIBA 01/2018 - 01/2010
13	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2015
13	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 08/2011
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2008
9	CytokinesIBA 03/2022 - 01/2016
9	Messenger RNA (mRNA)IBA 01/2021 - 01/2014
9	Glucose (Dextrose)FDA LinkGeneric 04/2020 - 05/2010
9	Mitochondrial DNA (mtDNA)IBA 04/2018 - 05/2010
8	LigandsIBA 01/2022 - 10/2005
8	Transfer RNA (tRNA)IBA 01/2021 - 05/2012
7	NucleotidesIBA 01/2020 - 06/2010
6	LipidsIBA 01/2022 - 09/2005
6	Anaplastic Lymphoma KinaseIBA 09/2020 - 01/2014
6	AcidsIBA 05/2020 - 10/2013
6	Hemagglutinins (Hemagglutinin)IBA 12/2017 - 08/2013
5	Biological ProductsIBA 01/2022 - 01/2011
5	azoreductaseIBA 03/2021 - 01/2018
5	Emodin (Archin)IBA 01/2021 - 11/2007
5	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 03/2015
5	EnzymesIBA 03/2020 - 07/2014
5	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2019 - 10/2013
5	Small Interfering RNA (siRNA)IBA 07/2019 - 01/2014
5	baicalinIBA 10/2014 - 10/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2009
4	VaccinesIBA 01/2022 - 12/2013
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2021 - 10/2018
4	AntioxidantsIBA 01/2021 - 11/2010
4	Phosphotransferases (Kinase)IBA 01/2021 - 08/2008
4	ErbB Receptors (EGF Receptor)IBA 11/2020 - 08/2014
4	CrizotinibIBA 01/2020 - 04/2017
4	Ser Transfer RNAIBA 12/2019 - 05/2010
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2019 - 08/2008
4	LeptinIBA 11/2018 - 07/2014
4	EstersIBA 12/2017 - 10/2013
4	CateninsIBA 05/2017 - 01/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2013 - 01/2011
3	Sincalide FDA Link 05/2022 - 01/2015
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 08/2008
3	Cadherins (E-Cadherin)IBA 12/2021 - 05/2017
3	Oxidoreductases (Dehydrogenase)IBA 07/2021 - 12/2016
3	BilirubinIBA 03/2021 - 11/2010
3	Ile Transfer RNAIBA 01/2021 - 06/2013
3	Phosphates (Orthophosphate)IBA 01/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 12/2020 - 10/2018
3	ParaquatIBA 03/2020 - 04/2018
3	Oxygen (Dioxygen)IBA 01/2020 - 10/2018
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 09/2010
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2015

Therapy/Procedure

39	Therapeutics 12/2022 - 11/2010
12	Drug Therapy (Chemotherapy) 01/2022 - 08/2013
5	Aftercare (After-Treatment) 05/2018 - 07/2009
4	Photochemotherapy (Photodynamic Therapy) 03/2021 - 10/2018
3	Renal Dialysis (Hemodialysis) 01/2022 - 01/2021
3	Immunotherapy 01/2022 - 01/2020
3	Precision Medicine 05/2020 - 05/2013